Anxiolytic effects of the neuroactive steroid pregnanolone (3α-OH-5β-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum

Brain Research

Volumn 850, Issue 1-2, 1999, Pages 217-224

  Bitran, Daniel ^a   Dugan, Matthew ^a   Renda, Phyllis ^a   Ellis, Rebecca ^a   Foley, Melissa ^a  

^a Department of Mathematics and Computer Science   (United States)

Author keywords

Anxiolytic; Defensive burying test; Elevated plus maze; Hippocampus; Lateral septum; Neurosteroid

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ELTANOLONE; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PICROTOXIN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; ENANTIOMER; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

EID: 0032711337     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02150-2     Document Type: Article

References (53)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviors respectively. Eur. J. Pharmacol. 264:1994;259-264.
2. Barbaccia M.L., Roscetti G., Bolacchi F., Concas A., Mostallino M.C., Purdy R.H., Biggio G. Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol. Biochem. Behav. 54:1996;205-210.
3. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., Biggio G. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 120:1997;1582-1588.
4. Belelli D., Lan N.C., Gee K.W. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14:1990;315-322.
5. Belzung C. Hippocampal mossy fibers: implication in novelty reactions or in anxiety behaviors? Behav. Brain Res. 51:1992;149-155.
6. A receptor. Brain Res. 561:1991;157-161.
7. A receptor function. Pharmacol. Biochem. Behav. 45:1993;423-428.
8. Bitran D., Shiekh M., Dowd J.A., Dugan M.M., Renda P. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors. Pharmacol. Biochem. Behav. 60:1998;879-888.
9. A receptors. J. Neuroendocrinol. 7:1995;171-177.
10. Brady J.V., Nauta W.J.H. Subcortical mechanisms in control of behavior. J. Comp. Physiol. Psychol. 48:1955;412-420.
11. A receptors. Eur. J. Pharmacol. 325:1997;1-7.
12. Carbone E., Wieland S., Lan N.C., Gee K.W. Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety. Psychopharmacology. 126:1996;173-178.
13. 1 hippocampus. J. Neurophysiol. 74:1995;464-469.
14. Devaud L.L., Purdy R.H., Morrow A.L. The neurosteroid 3α-hydroxy-5α-pregnan-20-one protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol.: Clin. Exp. Res. 19:1995;350-355.
15. Drugan R.C., Skolnick P., Paul S.M., Crawley J.N. Low doses of muscimol produce anticonflict actions in the lateral septum of the rat. Neuropharmacology. 25:1986;203-205.
16. Fernandez-Guasti A., Picazo O. Flumazenil blocks the anxiolytic action of allopregnanolone. Eur. J. Pharmacol. 281:1995;113-115.
17. A complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation. Mol. Pharmacol. 40:1991;995-999.
18. J.A. Gray, The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System, Oxford Univ. Press, London, 1982.
19. Grobin A.C., Roth R.H., Deutch A.Y. Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3α-21-dihydroxy-5α-pregnan-20-one. Brain Res. 578:1992;351-356.
20. A receptor complex. J. Pharmacol. Exp. Ther. 241:1987;346-353.
21. A receptor activation. Br. J. Pharmacol. 108:1993;711-716.
22. Huttunen P., Myers R.D. Tetrahydro-β-carboline microinjected into the hippocampus induces an anxiety-like state in the rat. Pharmacol. Biochem. Behav. 24:1986;1733-1738.
23. Jessa M., Nazar M., Plaznik A. Anxiolytic-like action of intra-hippocampally administered NMDA antagonists in rats. Pol. J. Pharmacol. 47:1995;81-84.
24. 1A agonistic anxiolytic. Neuropharmacology. 30:1991;475-480.
25. A receptor in the cerebral cortex: a non-corticosterone influence. Brain Res. 609:1993;244-252.
26. Kostowski W., Plaznik A., Stefanski R. Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168:1989;393-396.
27. 1 hippocampus in vitro of guinea-pigs and rats. Acta Physiol. Scand. 154:1995;165-176.
28. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
29. Norberg L., Wahlstrom G., Backstrom T. The anesthetic potency of 3α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one determined with an intravenous EEG-threshold in male rats. Pharmacol. Toxicol. 61:1987;42-47.
30. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
31. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
32. Pesold C., Treit D. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests. Physiol. Behav. 52:1992;37-47.
33. Pesold C., Treit D. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638:1994;295-301.
34. Pesold C., Treit D. The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam. Brain Res. 710:1996;161-168.
35. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res. 680:1995;135-141.
36. A receptor subunit composition? Rec. Chan. 1:1993;135-142.
37. Purdy R.H., Morrow A.L., Moore P.H.J., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4553-4557.
38. Schwartz-Giblin S., Felzenberg E.R., Robbins A., Pfaff D.W., McCarthy M.M. Diazepam and allopregnanolone infusions in midbrain central gray facilitate reproductive and open-field behaviors. Soc. Neurosci. Abstr. 19:1993;586.
39. A receptor subtype. Brain Res. Bull. 23:1989;317-322.
40. A receptor α4 subunit in association with increased anxiety. J. Neurosci. 18:1998;5275-5284.
41. Smith S.S., Waterhouse B.D., Woodward D.J. Locally applied progesterone metabolites alter neuronal responsiveness in the cerebellum. Brain Res. Bull. 18:1987;739-747.
42. Smythe J.W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol. Biochem. Behav. 56:1997;507-513.
43. 3 receptor antagonist. Neuropharmacology. 32:1993;987-993.
44. 1A receptor agonists. Neuropharmacology. 32:1993;977-985.
45. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav. Neurosci. 111:1997;653-658.
46. Treit D., Menard J. Intra-hippocampal midazolam is anxiolytic in the elevated plus-maze but not in the shock-probe burying test. Soc. Neurosci. Abstr. 24:1998;690.
47. D. Treit, J. Menard, C. Pesold, The shock-probe burying test., Neurosci. Protocols, 1994, 9-17.
48. Treit D., Pesold C., Rotzinger S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validate models of rat anxiety. Behav. Neurosci. 107:1993;770-785.
49. Wang M.D., Wahlstrom G., Gee K.W., Backstrom T. Potency of lipid and protein formulation of 5α-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution. Br. J. Anaesth. 74:1995;553-557.
50. Wieland S., Belluzzi J.D., Stein L., Lan N.C. Comparative behavioral characterization of the neuroactive steroids 3α-OH, 5α-pregnan-20-one and 3α-OH, 5β-pregnan-20-one in rodents. Psychopharmacology. 118:1995;65-71.
51. Wieland S., Lan N.C., Mirasedeghi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 565:1991;263-268.
52. Yadin E., Thomas E., Grishkat H.L., Strickland C.E. The role of the lateral septum in anxiolysis. Physiol. Behav. 53:1993;1077-1083.
53. A receptors. J. Neurosci. 16:1996;6648-6656.